focus -WSS

focus

author：comprehensive 2025-08-29 19:54:11 - browse：38559

Rising drug prices —Medicare coverage from STAT — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start. APStock

WASHINGTON — Medicare on Friday released new details about how its new drug price negotiation program will work, just two months before it’s set to start.

Medicare released an initial outline of how the program will work in March. Some parts, including the outline of how drugs would be selected for the negotiation process, were immediately final. The agency asked drug companies, patients, and other affected parties to weigh in on other parts about how the process would proceed, what factors would be considered, and how drugmakers would be held accountable.

Newsletters

Sign up for D.C. Diagnosis

An insider's guide to the politics and policies of health care

Please enter a valid email address. Privacy Policy

The negotiation process was created last August in Democrats’ drug pricing reform law, and Medicare is supposed to select the first 10 drugs that will be subject to negotiation by Sept. 1.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Diversity in medical illustrations gets boost from Chidiebere Ibe

hotspot

WSS

NYU Langone launches private ChatGPT for its health care data

FDA panel gives mixed vote on blood pressure devices

How Vertex's cystic fibrosis drug is changing patients' lives

Medicare explains how it will choose drugs for negotiation

Apellis safety probe of eye disease drug centers on injection needle

Medical student insurance fails on mental health care coverage

focus

focus

Sign up for D.C. Diagnosis

focus

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Radiation, mainstay of cancer treatment, begins a fade

After affirmative action ruling, medical educators look to 'holistic review'

CDC advisers recommend seasonal use of Pfizer RSV shot

Duchenne breakthrough therapy leaves behind pioneering families

Lasker Awards 2023: Winners in biomedical research

Alkermes shareholders re

EpiPen alternative approval delay highlights citizen petition issue

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Senate HELP committee spars over health care workforce policies

Wikipedia

How to make AI work for medicine

Neuroscience startup Neumora files for IPO

Biotech stock slump in 2023: awaiting the turnaround

NYU Langone launches private ChatGPT for its health care data

Psilocybin's anti

What Congress can do to address the rural doctor shortage

hotspot

knowledge

hotspot

Wikipedia